Downregulation of membrane-associated regulators, such as membrane cofactor protein (MCP) and decay-accelerating factor (DAF), in AMD results in dysregulated CFH and CFI activity, leading to aberrant activation of the alternative pathway [311-314]. Here, CD46 is linked to age-related macular degeneration.